Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2022 | Metabolic-Associated Fatty Liver Disease, Hepatitis B Surface Antigen Seroclearance, and Long-Term Risk of Hepatocellular Carcinoma in Chronic Hepatitis B | MING-WHEI YU ; Lin, Chih-Lin; CHUN-JEN LIU ; Wu, Wan-Jung; Hu, Jui-Ting; Huang, Yi-Wen | Cancers | 2 | 1 | |
2012 | Presence of serum HBV RNA predicts initial virological response in nucleoside analogue treated chronic hepatitis B patients | Huang, Yi-Wen; Takahashi, Shoichi; Tsuge, Masataka; Abe, Hiromi; Hu, Jui-Ting; Chen, Pei-Jer; Chen, Ding-Shinn; Yang, Sien-Sing; Chayama, Kazuaki; Kao, Jia-Horng | Hepatology | | | |
2012 | Presence of serum HBV RNA predicts initial virological response in nucleoside analogue treated chronic hepatitis B patients | Huang, Yi-Wen; Takahashi, Shoichi; Tsuge, Masataka; Abe, Hiromi; Hu, Jui-Ting; Chen, Pei-Jer; Chen, Ding-Shinn; Yang, Sien-Sing; Chayama, Kazuaki; Kao, Jia-Horng | Hepatology | | | |
2023 | Prevention and management of tuberculosis in solid organ transplantation: A consensus statement of the transplantation society of Taiwan | Chiang, Chen-Yuan; Chen, Cheng-Hsu; Feng, Jia-Yih; Chiang, Yang-Jen; Huang, Wei-Chang; Lin, Yih-Jyh; Huang, Yi-Wen; Wu, Hsin-Hsu; Lee, Pin-Hui; Lee, Ming-Che; CHIN-CHUNG SHU ; Wang, Hsu-Han; JANN-YUAN WANG ; Wu, Mei-Yi; CHIH-YUAN LEE ; Wu, Mai-Szu | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 1 | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2014 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Peng, Cheng-Yuan; Chien, Rong-Nan; Mo, Lein-Ray; Huang, Yi-Wen; Chen, Ming-Yao; Lin, Chih-Lin; Chen, Tsung-Ming; Wang, Horng-Yuan; Tseng, Kuo-Chih; Yang, Sheng-Shun; Hsu, Shih-Jer; Suk, Fat-Moon; Hu, Chi-Tan; Hsieh, Tsai-Yuan; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2013 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - An interim report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Lin, Chun-Che; Peng, Cheng-Yuan; Chuang, Wan-Long; Chen, Chi-Yi; Wang, Chia-Chi; Chien, Rong-Nan; Huang, Yi-Hsiang; Lin, Chih-Lin; Yang, Sheng-Shun; Huang, Yi-Wen; Hsu, Shih-Jer; Wang, Horng-Yuan; Mo, Lein-Ray; Ming-jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Lei, Yung-Chao; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2015 | Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study | Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng | Hepatology | | | |
2015 | Reply to: Modulation of Toll-like receptor 9 expression on monocytes of viral hepatitis patients | Huang, Yi-Wen; Yang, Sien-Sing; Kao, Jia-Horng | Antiviral Therapy | 0 | 0 | |
2021 | Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C | SHIH-JER HSU ; Yu, Ming-Lung; Su, Chien-Wei; Peng, Cheng-Yuan; Chien, Rong-Nan; Lin, Hsien-Hong; Lo, Gin-Ho; Su, Wei-Wen; Kuo, Hsing-Tao; Hsu, Chao-Wei; Yang, Sien-Sing; Yang, Sheng-Shun; Tseng, Kuan-Chiao; Qin, Albert; Huang, Yi-Wen; Chuang, Wan-Long | Journal of the Formosan Medical Association = Taiwan yi zhi | 14 | 12 | |
2022 | Topical Tirbanibulin, a Dual Src Kinase and Tubulin Polymerization Inhibitor, for the Treatment of Plaque-Type Psoriasis: Phase I Results | JIN-BON HONG ; Wu, Po-Yuan; Qin, Albert; Huang, Yi-Wen; Tseng, Kuan-Chiao; Lai, Ching-Yu; Chan, Wing-Kai; Fang, Jane; Cutler, David L; TSEN-FANG TSAI | Pharmaceutics | 1 | 1 | |